Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine
Launched by GUANG'ANMEN HOSPITAL OF CHINA ACADEMY OF CHINESE MEDICAL SCIENCES · Sep 29, 2021
Trial Information
Current as of June 29, 2025
Completed
Keywords
ClinConnect Summary
The diagnostic criteria for type 2 diabetes mellitus and obesity are based on the Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). The diagnostic criteria of dyslipidaemia are based on the Chinese Guidelines on Prevention and Treatment of Dyslipidaemia in Adults (2016, revision edition).
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Meet at least three of the requirements below; 1) Fasting Plasma Glucose \> 6.1 mmol/L or 2-hour Postprandial Blood Glucose \> 7.8 mmol/L or diagnosed as type 2 diabetes mellitus; 2) Body Mass Index \> 25 kg / m2; 3) Total Cholesterol \> 5.2 mmol / L; Or Triglyceride \> 1.70 mmol / L; Or Low-Density Lipoprotein \> 3.12 mmol / L; Or High-Density Lipoprotein \< 1.04 mmol/L. 4) Systolic blood pressure \> 130 mmHg or Diastolic blood pressure \> 85 mmHg or diagnosed as hypertension;
- • 2. Received 6 months of continuous Chinese herbal medicine treatment;
- • 3. During the period of receiving Chinese herbal medicine, the patients continued to take western medicine according to the doctor's advice as before.
- • 4. During the period of receiving Chinese herbal medicine, diet and exercise continued according to the original routine, and the tests would be reviewed in the same institution.
- • 5. Aged 18 to 80 years at the time of their consent;
- • 6. Signed informed consent.
- Exclusion Criteria:
- • Patients who had serious heart, lung, liver, kidney and brain diseases; serious infectious or hemorrhagic diseases; serious nervous system diseases, mental instability; or could not cooperate with treatment were excluded.
About Guang'anmen Hospital Of China Academy Of Chinese Medical Sciences
Guang'anmen Hospital, part of the China Academy of Chinese Medical Sciences, is a leading institution dedicated to advancing traditional Chinese medicine through rigorous scientific research and clinical practice. Renowned for its commitment to integrating traditional and modern medical approaches, the hospital serves as a pivotal center for clinical trials aimed at evaluating the efficacy and safety of innovative therapies. With a multidisciplinary team of experts and state-of-the-art facilities, Guang'anmen Hospital strives to contribute to the global medical community by promoting evidence-based practices and enhancing patient care through comprehensive research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Jiaxing Tian, PhD
Principal Investigator
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials